Hims & Hers 與禮來達成GLP-1協議，其股價正在上漲。根據協議，Hims表示將停止復配Zepbound等GLP-1藥物。引述“Hims表示，未來將不再復配Zepbound等GLP-1藥物。”— Hims & Hers來源Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.MarketWatch